XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.1
SELECTED FINANCIAL STATEMENT INFORMATION
6 Months Ended
Apr. 30, 2021
Selected Financial Statement Information [Abstract]  
Selected Financial Statement Information [Text Block] SELECTED FINANCIAL STATEMENT INFORMATION
Accounts Receivable
(in thousands)April 30, 2021October 31, 2020
Accounts receivable$227,613 $223,171 
Less: Allowance for doubtful accounts(11,877)(12,738)
Accounts receivable, net$215,736 $210,433 

Inventories
(in thousands)April 30, 2021October 31, 2020
Finished products$227,956 $235,501 
Work in process41,393 37,957 
Materials, parts, assemblies and supplies193,237 189,747 
Inventories, net of valuation reserves$462,586 $463,205 

Property, Plant and Equipment
(in thousands)April 30, 2021October 31, 2020
Land$10,969 $6,678 
Buildings and improvements130,901 120,769 
Machinery, equipment and tooling274,521 265,408 
Construction in progress7,846 8,487 
424,237 401,342 
Less: Accumulated depreciation and amortization(246,922)(232,494)
Property, plant and equipment, net$177,315 $168,848 

Accrued Customer Rebates and Credits

The aggregate amount of accrued customer rebates and credits included within accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets was $15.3 million and $15.8 million as of April 30, 2021 and October 31, 2020, respectively. The total customer rebates and credits deducted within net sales for the six months ended April 30, 2021 and 2020 was $1.8 million and $3.8 million, respectively. The total customer rebates and credits deducted within net sales for the three months ended April 30, 2021 and 2020 was $1.0 million and $1.7 million, respectively.
Research and Development Expenses

The amount of new product research and development ("R&D") expenses included in cost of sales for the six and three months ended April 30, 2021 and 2020 is as follows (in thousands):
Six months ended April 30,Three months ended April 30,
2021202020212020
R&D expenses$34,203 $33,855 $18,022 $16,752 

Redeemable Noncontrolling Interests

The holders of equity interests in certain of the Company's subsidiaries have rights ("Put Rights") that may be exercised on varying dates causing the Company to purchase their equity interests through fiscal 2030. The Put Rights, all of which relate either to common shares or membership interests in limited liability companies, provide that the cash consideration to be paid for their equity interests (the "Redemption Amount") be at fair value or a formula that management intended to reasonably approximate fair value based solely on a multiple of future earnings over a measurement period. Management's estimate of the aggregate Redemption Amount of all Put Rights that the Company could be required to pay is as follows (in thousands):
April 30, 2021October 31, 2020
Redeemable at fair value $181,918 $179,415 
Redeemable based on a multiple of future earnings41,348 41,793 
Redeemable noncontrolling interests$223,266 $221,208 
    
Accumulated Other Comprehensive Income (Loss)

Changes in the components of accumulated other comprehensive income (loss) for the six months ended April 30, 2021 are as follows (in thousands):
Foreign Currency TranslationDefined Benefit Pension PlanAccumulated
Other
Comprehensive Income (Loss)
Balances as of October 31, 2020($6,460)($2,689)($9,149)
Unrealized gain10,755 — 10,755 
Amortization of unrealized loss — 68 68 
Balances as of April 30, 2021$4,295 ($2,621)$1,674